Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18585971

3-year study of donepezil therapy in Alzheimer's disease : Effects of early and continuous therapy

Author
WINBLAD, B1 ; WIMO, A2 ; ENGEDAL, K3 ; SOININEN, H4 ; VERHEY, F5 ; WALDEMAR, G6 ; WETTERHOLM, A.-L7 ; HAGLUND, A7 ; ZHANG, R8 ; SCHINDLER, R8
[1] Karolinska University Hospital Huddinge, Stockholm, Sweden
[2] Neurotec, Karolinska Institutet, Stockholm, Sweden
[3] Department of Geriatric Medicine, Ullevaal University Hospital, Oslo, Norway
[4] Department of Neurology, University and University Hospital of Kuopio, Kuopio, Finland
[5] Department of Psychiatry, Institute of Brain and Behaviour, Maastricht Hospital University, Maastricht, Netherlands
[6] The Neuroscience Center, Department of Neurology, Rigshospitalet, University Hospital, Copenhagen, Denmark
[7] Pfizer, Täby, Sweden
[8] Pfizer Global Pharmaceuticals, Pfizer, New York, N.Y, United States
Donepezil Nordic Study Group
Source

Dementia and geriatric cognitive disorders. 2006, Vol 21, Num 5-6, pp 353-363, 11 p ; ref : 40 ref

ISSN
1420-8008
Scientific domain
Gerontology geriatrics; Neurology; Psychology, psychopathology, psychiatry
Publisher
Karger, Basel
Publication country
Switzerland
Document type
Article
Language
English
Author keyword
Alzheimer's disease, donepezil therapy Delayed-start therapy, donepezil Donepezil, Alzheimer's disease Long-term efficacy, donepezil Long-term safety, donepezil Open-label donepezil
Keyword (fr)
Antialzheimer Donépézil Démence Alzheimer Démence Nootrope Psychotrope Système nerveux pathologie Traitement Trouble cognition Acetylcholinesterase Anticholinestérasique Carboxylic ester hydrolases Encéphale pathologie Enzyme Esterases Hydrolases Inhibiteur enzyme Maladie dégénérative Pipéridine dérivé Système nerveux central pathologie
Keyword (en)
Antialzheimer agent Donepezil Alzheimer disease Dementia Nootropic agent Psychotropic Nervous system diseases Treatment Cognitive disorder Acetylcholinesterase Anticholinesterase agent Carboxylic ester hydrolases Cerebral disorder Enzyme Esterases Hydrolases Enzyme inhibitor Degenerative disease Piperidine derivatives Central nervous system disease
Keyword (es)
Antialzheimer Donepezilo Demencia Alzheimer Demencia Nootropo Psicotropo Sistema nervioso patología Tratamiento Trastorno cognitivo Acetylcholinesterase Anticolinesterasa agente Carboxylic ester hydrolases Encéfalo patología Enzima Esterases Hydrolases Inhibidor enzima Enfermedad degenerativa Piperidina derivado Sistema nervosio central patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02G Blood. Blood coagulation. Reticuloendothelial system

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17C Vascular diseases and vascular malformations of the nervous system

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases

Discipline
Neurology Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18585971

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web